- Trump signs order to fast-track research on psychedelic drugs Euronews —
- Donald Trump signs order to expedite access to psychedelics Times Of India —
- Trump signs order to accelerate access to psychedelic drug treatments The Japan Times —
- Trump signs executive order accelerating research into psychedelic drug therapies ABC News —
- Trump joined by Joe Rogan as he signs order to speed up psychedelic review Al Jazeera —
- Trump signs order to speed review of psychedelics, including the controversial drug ibogaine 6abc Philadelphia —
- Trump signs order easing restrictions on psychedelic drugs The Straits Times —
- Trump jokes about asking for ibogaine at executive order signing on psychedelics NBC News —
- Trump jokes about asking for ibogaine at executive order signing NBC News —
- Trump signs order to speed review of psychedelics, including ibogaine AP News —
- Trump signs order to speed review of psychedelics, including the controversial drug ibogaine The Independent —
- Trump Announces 'Historic' Drug Reforms In Boost For Veterans Newsweek —
- Trump issues executive order on psychedelic drugs Seeking Alpha —
- Trump Signs Order Easing Restrictions on Psychedelic Drugs Bloomberg —
- Trump signs order to fast track psychedelic drug research to treat veterans with PTSD NY Post —
- Trump signs order to research psychedelic used abroad to treat PTSD CBS News —
- Trump announces reforms to accelerate access to psychedelic drug treatments - Reuters Reuters —
- Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs Fox News —
- LIVE: President Trump signs executive order ABC News —
- Live: Trump signs executive order CNN —
Ibogaine
Chemical compound
Ibogaine is a psychoactive indole alkaloid derived from plants such as Tabernanthe iboga, characterized by hallucinogenic and oneirogenic effects. Traditionally used by Central African foragers, it has undergone controversial research for the treatment of substance use disorders. Ibogaine exhibits complex pharmacology by interacting with multiple neurotransmitter systems, notably affecting opioid, serotonin, sigma, NMDA, and nicotinic acetylcholine receptors; its metabolite noribogaine primarily acts as a serotonin reuptake inhibitor and κ-opioid receptor agonist.
Also known as...
12-methoxyibogaminePresident Trump signed an executive order to accelerate research into psychedelic drugs for mental health treatment.